BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 38195591)

  • 1. Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.
    Seaton G; Smith H; Brancale A; Westwell AD; Clarkson R
    Mol Cancer; 2024 Jan; 23(1):7. PubMed ID: 38195591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
    Legge DN; Shephard AP; Collard TJ; Greenhough A; Chambers AC; Clarkson RW; Paraskeva C; Williams AC
    Dis Model Mech; 2019 Mar; 12(3):. PubMed ID: 30792270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.
    Zhang Q; Didonato JA; Karin M; McKeithan TW
    Mol Cell Biol; 1994 Jun; 14(6):3915-26. PubMed ID: 8196632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
    Wu J; Li L; Jiang G; Zhan H; Wang N
    Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
    Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
    J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter.
    Kim YM; Sharma N; Nyborg JK
    J Virol; 2008 Dec; 82(23):11939-47. PubMed ID: 18815299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
    Edwards RH; Marquitz AR; Raab-Traub N
    mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).
    Kuo SH; Tsai HJ; Lin CW; Yeh KH; Lee HW; Wei MF; Shun CT; Wu MS; Hsu PN; Chen LT; Cheng AL
    J Pathol; 2017 Feb; 241(3):420-433. PubMed ID: 27873317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity.
    Wang VY; Li Y; Kim D; Zhong X; Du Q; Ghassemian M; Ghosh G
    Mol Cell; 2017 Aug; 67(3):484-497.e5. PubMed ID: 28689659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare double-hit with two translocations involving IGH both, with BCL2 and BCL3, in a monoclonal B-cell lymphoma/leukemia.
    Alpatov R; Carstens B; Harding K; Jarrett C; Balakhani S; Lincoln J; Brzeskiewicz P; Guo Y; Ohene-Mobley A; LeRoux J; McDaniel V; Meltesen L; Minka D; Patel M; Manavi C; Swisshelm K
    Mol Cytogenet; 2015; 8():101. PubMed ID: 26719766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Bcl3 Disrupts Viability of Breast Cancer Cells through Both p53-Dependent and p53-Independent Mechanisms via Loss of NF-κB Signalling.
    Turnham DJ; Smith H; Clarkson RWE
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycopene treatment inhibits activation of Jak1/Stat3 and Wnt/β-catenin signaling and attenuates hyperproliferation in gastric epithelial cells.
    Park B; Lim JW; Kim H
    Nutr Res; 2019 Oct; 70():70-81. PubMed ID: 30098838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL3 exerts an oncogenic function by regulating STAT3 in human cervical cancer.
    Zhao H; Wang W; Zhao Q; Hu G; Deng K; Liu Y
    Onco Targets Ther; 2016; 9():6619-6629. PubMed ID: 27822067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells.
    Poveda J; Sanz AB; Carrasco S; Ruiz-Ortega M; Cannata-Ortiz P; Sanchez-Niño MD; Ortiz A
    Exp Mol Med; 2017 Jul; 49(7):e352. PubMed ID: 28684863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
    Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F
    Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.
    Song L; Wörmann S; Ai J; Neuhöfer P; Lesina M; Diakopoulos KN; Ruess D; Treiber M; Witt H; Bassermann F; Halangk W; Steiner JM; Esposito I; Rosendahl J; Schmid RM; Riemann M; Algül H
    Gastroenterology; 2016 Feb; 150(2):499-512.e20. PubMed ID: 26526716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
    Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
    Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
    Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.
    Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA
    Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.